|
GS135315: alcohol preference 3 QTL (Ap3q, Published QTL Chr 4)
|
|
GS135831: fluctuating asymmetry QTL 1 (Faq1, Published QTL Chr 4)
|
|
GS135544: corpus callosum hemisphere surface size 2 (Ccrs2, Published QTL Chr 4)
|
|
GS136518: phospholipid transfer protein inducibility QTL 1 (Pltiq1, Published QTL Chr 4)
|
|
GS135221: aromatase activity QTL 2 (Aaiq2, Published QTL Chr 4)
|
|
GS135220: aromatase activity QTL 1 (Aaiq1, Published QTL Chr 4)
|
|
GS209907: GO:0004175 endopeptidase activity
|
|
GS84321: pentobarbital withdrawal Chr4 (Published QTL)
|
|
GS178461: GO:0009987 cellular process
|
|
GS188685: GO:0070011 peptidase activity, acting on L-amino acid peptides
|
|
GS184852: GO:0072503 cellular divalent inorganic cation homeostasis
|
|
GS84165: ethanol conditioned taste aversion (Published QTL, Chr 4)
|
|
GS192965: GO:0004175 endopeptidase activity
|
|
GS129116: cytokine induced activation 3 (Cinda3 Published QTL Chr 4)
|
|
GS192667: GO:0055080 cation homeostasis
|
|
GS83998: cocaine and amphetamine-regulated transcript QTL 2 (Crq2, Published QTL, Chr 4)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS35292: Hippocampus Gene expression correlates of Prepulse inhibition at 85db in Females BXD
|
|
GS196943: GO:0008152 metabolic process
|
|
GS136150: "lupus in MRL and B6 F2 cross, QTL 1" (Lmb1, Published QTL Chr 4)
|
|
GS136772: SGC/Knj cross B6 QTL 1 (Sxbq1, Published QTL Chr 4)
|
|
GS183767: GO:0019725 cellular homeostasis
|
|
GS196941: GO:0008150 biological_process
|
|
GS136580: red blood cell QTL 2 (Rbcq2, Published QTL Chr 4)
|
|
GS136916: vertebral morphology and mechanical traits 4 (Vmmt4, Published QTL Chr 4)
|
|
GS136705: systemic lupus erythmatosus suppressor 2 (Sles2, Published QTL Chr 4)
|
|
GS135350: Alzheimer's disease modifier 2 (Azdm2, Published QTL Chr 4)
|
|
GS135567: cytokine deficiency colitis susceptibility 9 (Cdcs9, Published QTL Chr 4)
|
|
GS187511: GO:0017171 serine hydrolase activity
|
|
GS136621: sucrose consumption 2 (Scon2, Published QTL Chr 4)
|
|
GS135894: gastritis type A susceptibility locus 2 (Gasa2, Published QTL Chr 4)
|
|
GS136100: lupus NZB x NZW 2 (Lbw2, Published QTL Chr 4)
|
|
GS83985: cocaine related behavior 16 (Cocrb16, Published QTL, Chr 4)
|
|
GS199468: GO:0006508 proteolysis
|
|
GS184503: GO:0006874 cellular calcium ion homeostasis
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS136608: colon tumor susceptibility 11 (Scc11, Published QTL Chr 4)
|
|
GS136443: peak bone mineral density 3 (Pbmd3, Published QTL Chr 4)
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS84164: cocaine related behavior (Published QTL, Chr 4)
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS135893: gastritis type A susceptibility locus 1 (Gasa1, Published QTL Chr 4)
|
|
GS136191: light induced retinal degeneration 2 (Lrdg2, Published QTL Chr 4)
|
|
GS184506: GO:0006873 cellular ion homeostasis
|
|
GS128576: Ethanol induced LORR Chr# 4
|
|
GS84163: alcohol preference 3 QTL (Ap3q, Published QTL, Chr 4)
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS136719: susceptibility to lung cancer 21 (Sluc21, Published QTL Chr 4)
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS35307: Hippocampus Gene expression correlates of Acoustic Startle Response Percentage of maximum startle response at 80 db in Females & Males BXD
|
|
GS129104: bone mineral density 7 (Bmd7 Published QTL Chr 4)
|
|
GS182209: GO:0008233 peptidase activity
|
|
GS135899: granulosa cell tumorigenesis 1 (Gct1, Published QTL Chr 4)
|
|
GS205544: GO:0070011 peptidase activity, acting on L-amino acid peptides
|
|
GS136559: QTL for body weight independent of sex 1 (Qbis1, Published QTL Chr 4)
|
|
GS192669: GO:0055082 cellular chemical homeostasis
|
|
GS199006: GO:0008233 peptidase activity
|
|
GS136575: recognized antigen from MCA-induced tumor 1 (Ramt1, Published QTL Chr 4)
|
|
GS136689: skull morphology 6 (Skull6, Published QTL Chr 4)
|
|
GS135775: epistatic circling B C57L/J (Eclb, Published QTL Chr 4)
|
|
GS189904: GO:0008236 serine-type peptidase activity
|
|
GS35312: Hippocampus Gene expression correlates of Acoustic Startle Response Percentage of maximum response at 85 db in Females BXD
|
|
GS135803: elevated serum gp70 1 (Elsgp1, Published QTL Chr 4)
|
|
GS84166: METH responses for climbing (Published QTL, Chr 4)
|
|
GS135839: femoral bone trait QTL 2 (Fbtq2, Published QTL Chr 4)
|
|
GS136823: triglyceride QTL 3 (Tgq3, Published QTL Chr 4)
|
|
GS206788: GO:0008236 serine-type peptidase activity
|
|
GS184849: GO:0072507 divalent inorganic cation homeostasis
|
|
GS136046: insulin dependent diabetes susceptibility 25 (Idd25, Published QTL Chr 4)
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS135460: bone mineral density 6 (Bomd6, Published QTL Chr 4)
|
|
GS135509: body weight at 8 weeks QTL 2 (Bw8q2, Published QTL Chr 4)
|
|
GS135852: fecundity QTL 2 (Fecq2, Published QTL Chr 4)
|
|
GS35287: Hippocampus Gene expression correlates of Prepulse inhibition at 80db in Females & Males BXD
|
|
GS121837: bexarotene interacting genes (MeSH:C095105) in CTD
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS190124: GO:0042592 homeostatic process
|
|
GS136860: thermal pain response 1 (Tpnr1, Published QTL Chr 4)
|
|
GS180164: GO:0008150 biological_process
|
|
GS135416: beta-carboline-induced seizures 1 (Bis1, Published QTL Chr 4)
|
|
GS136050: insulin dependent diabetes susceptibility 9 (Idd9, Published QTL Chr 4)
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS35849: Neocortex Gene expression correlates of Cocaine CPP - difference in time spent relative to baseline drug exposure in Females BXD
|
|
GS136730: susceptibility to lung cancer 6 (Sluc6, Published QTL Chr 4)
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS180152: GO:0065007 biological regulation
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS136820: triglyceride level suppressor 1 (Tgls1, Published QTL Chr 4)
|
|
GS179672: GO:0030003 cellular cation homeostasis
|
|
GS129075: alloantigen response 2 (Alan2 Published QTL Chr 4)
|
|
GS135245: adiposity 12 (Adip12, Published QTL Chr 4)
|
|
GS135480: bone response to mechanical loading 13 (Brml13, Published QTL Chr 4)
|
|
GS178962: GO:0004252 serine-type endopeptidase activity
|
|
GS135770: ear healing QTL 2 (Earheal2, Published QTL Chr 4)
|
|
GS204377: GO:0017171 serine hydrolase activity
|
|
GS136788: TallyHo associated mesenteric fat pad weight (Tafat, Published QTL Chr 4)
|
|
GS135917: graft-versus-host disease 2 (Gvhd2, Published QTL Chr 4)
|
|
GS136148: lithogenic gene 8 (Lith8, Published QTL Chr 4)
|
|
GS36763: Cerebellum Gene expression correlates of Vocalization Threshold - shock intensity (mA) in Males BXD
|
|
GS188977: GO:0055074 calcium ion homeostasis
|
|
GS184502: GO:0006875 cellular metal ion homeostasis
|
|
GS135477: bone response to mechanical loading 10 (Brml10, Published QTL Chr 4)
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS136056: IgA nephropathy QTL 2 (Ignpq2, Published QTL Chr 4)
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS181708: GO:0050801 ion homeostasis
|
|
GS136567: retinoic acid induced forelimb autopod reduction 2 (Rafar2, Published QTL Chr 4)
|
|
GS135920: graft-versus host disease 5 (Gvhd5, Published QTL Chr 4)
|
|
GS135330: autoimmune renal vasculitis 2 (Arvm2, Published QTL Chr 4)
|
|
GS195719: GO:0004252 serine-type endopeptidase activity
|
|
GS191593: GO:0055065 metal ion homeostasis
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS135741: dystrophic cardiac calcinosis 2 (Dyscalc2, Published QTL Chr 4)
|
|
GS201367: GO:0019538 protein metabolic process
|
|
GS136202: lung tumor shape-determining 4 (Ltsd4, Published QTL Chr 4)
|
|
GS182673: GO:0006508 proteolysis
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS129084: atherosclerosis susceptibility QTL 1 (Athsq1 Published QTL Chr 4)
|
|
GS136667: skin tumor susceptibility 7 (Skts7, Published QTL Chr 4)
|
|
GS194087: GO:0003674 molecular_function
|
|
GS177356: GO:0003674 molecular_function
|
|
GS136880: tooth shape 6 (Tshp6, Published QTL Chr 4)
|
|
GS180142: GO:0048878 chemical homeostasis
|
|
GS136757: startle response 2 (Start2, Published QTL Chr 4)
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS136540: psoriasis susceptibility 6 (Psrs6, Published QTL Chr 4)
|
|
GS135607: circulating hormone level QTL 16 (Chlq16, Published QTL Chr 4)
|
|
GS135856: femoral bone morphometry 5 (Fembm5, Published QTL Chr 4)
|
|
GS180166: GO:0008152 metabolic process
|
|
GS135394: body growth early QTL 3 (Bgeq3, Published QTL Chr 4)
|